Edwards Lifesciences Corporation (EW)

Edwards Lifesciences Corporation (EW) is a healthcare company (medical devices) based in the United States. The share price is $107.40, up 0.27% on the day, which values the company at $61.75B. Price as of 17 Nov 2026, 17:14 UTC, from Yahoo Finance.

Key facts

Share price
$107.40+0.27% today
Market value
$61.75B
P/E ratio
62.4×last 12 months
Forward P/E
31.7×
Funk Score
63/100
Against its own history
Above its usual priceusual price $87.52
200-week average
$80.1034% above
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Edwards Lifesciences Corporation in more detail

EW trades at 62.4× its last twelve months' earnings, 31.7× next year's expected earnings, 9.3× sales. Measured against its own history, the price is 23% above what its usual multiples would imply ($87.52) — above its usual price. It sits 34% above its 200-week average of $80.10.

Over the last five fiscal years Edwards Lifesciences Corporation has compounded revenue 6.7% a year, earnings per share 7.1% a year, free cash flow 15.6% a year. Its Funk Score is 63 out of 100 (financial strength 9.3, profitability 7.5, growth 5.9, value 2.3, each out of 10).

In its favour: Altman Z in the safe zone; Share count keeps falling. Worth checking: Gross margin is shrinking.

9 of the superinvestors tracked here hold EW, including David Rolfe (3.1% of the portfolio), Howard Gleicher (1.6% of the portfolio), Brandon Haley (0.7% of the portfolio).

Superinvestors holding EW

9 of the investors tracked here report a position in their latest 13F filing.

Compare

Health Care companies of similar size

Side by side:EW vs ARGX (Edwards Lifesciences Corporation vs argenx)EW vs BDX (Edwards Lifesciences Corporation vs Becton, Dickinson)EW vs CAH (Edwards Lifesciences Corporation vs Cardinal Health)EW vs BSX (Edwards Lifesciences Corporation vs Boston Scientific)EW vs IDXX (Edwards Lifesciences Corporation vs IDEXX Laboratories)

All health care companies by market valueLargest companies in the United StatesAll stocks A–Z

Edwards Lifesciences Corporation (EW): questions and answers

What is EW's P/E ratio?

Edwards Lifesciences Corporation trades at 62.4× its last twelve months' earnings and 31.7× next year's expected earnings. At its fiscal year-ends over the past 18 years the P/E ranged from 10.6× to 70.2×, with a median of 35.8×.

What is EW's PEG ratio?

Edwards Lifesciences Corporation's PEG ratio is 2.36 — its P/E divided by its expected earnings growth. Around 1 is the classic sign of a price that matches the growth; well above it means the growth is being paid for in advance.

What is Edwards Lifesciences Corporation's market cap?

Edwards Lifesciences Corporation is valued at $61.75B at a share price of $107.40.

Is EW overvalued or undervalued?

Against its own history, EW is above its usual price: the price is 23% above the $87.52 implied by the median multiples it has traded at (price / earnings, price / sales, price / book, price / free cash flow). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

Is EW above its 200-week moving average?

Yes. EW is 34.1% above its 200-week average of $80.10. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is Edwards Lifesciences Corporation growing?

Over the last five fiscal years Edwards Lifesciences Corporation's revenue grew 6.7% a year and its earnings per share 7.1% a year; over ten years revenue grew 9.3% a year.

Cite this page

Funkfolio, “Edwards Lifesciences Corporation (EW) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/EW

Underlying data: Yahoo Finance; company filings with the SEC.